Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: case series

dc.creator	Dogan, Lerzan
dc.creator	Kaya, Dilaver
dc.creator	Sarikaya, Tugce
dc.creator	Zengin, Rehile
dc.creator	Dincer, Alp
dc.creator	Akinci, Ibrahim Ozkan
dc.creator	Afsar, Nazire
dc.date.accessioned	2020-07-07T16:35:11Z
dc.date.available	2020-07-07T16:35:11Z
dc.date.issued	2020-07
dc.description.abstract	Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).	pt_BR
dc.identifier.citation	DOGAN, L. et al. Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: case series. Brain, Behavior, and Immunity, [S.l.], v. 87, p. 155-158, July 2020.	pt_BR
dc.identifier.uri	https://repositorio.ufla.br/handle/1/41741
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S0889159120308035	pt_BR
dc.language	en_US	pt_BR
dc.publisher	Elsevier	pt_BR
dc.rights	openAccess	pt_BR
dc.source	Brain, Behavior, and Immunity	pt_BR
dc.subject	Autoimmune	pt_BR
dc.subject	Encephalitis	pt_BR
dc.subject	COVID-19	pt_BR
dc.subject	Plasmapheresis	pt_BR
dc.title	Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: case series	pt_BR
dc.type	Artigo	pt_BR

Arquivos

Agora exibindo 1 - 1 de 1